Characteristics and Outcomes of Pediatric Patients Supported With Ventricular Assist Device-A Multi-Institutional

Kriti Puri1, Marc M Anders2, Sebastian C Tume2

  • 1Lillie Frank Abercrombie Section of Cardiology, Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston, TX.

Insights

Pediatric ventricular assist device use is growing, with more patients discharged on support. Congenital heart disease, renal failure, sepsis, stroke, and ECMO increase mortality risk in these children.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Surgery
  • Critical Care Medicine

Background:

  • Ventricular assist devices (VADs) are increasingly used in pediatric heart failure patients.
  • This use is associated with significant morbidity and mortality.
  • Understanding outcomes and resource utilization is crucial for improving care.

Purpose of the Study:

  • To describe admission outcomes for pediatric patients receiving VAD support.
  • To analyze resource utilization in this patient population.
  • To identify factors associated with mortality and resource use.

Main Methods:

  • Retrospective cohort analysis of the Pediatric Health Information System database (2006-2015).
  • Included admissions for patients ≤21 years old with VAD implantation.
  • Primary outcome: hospital mortality; secondary outcomes: length of stay and adjusted cost.

Main Results:

  • Analyzed 744 VAD implantations in 740 pediatric patients.
  • Overall hospital mortality was 25%; 53% received a transplant, 19% were discharged on VAD.
  • Factors associated with mortality included congenital heart disease, renal failure, sepsis, stroke, and extracorporeal membrane oxygenation (ECMO).

Conclusions:

  • Pediatric VAD use is increasing, with a higher proportion discharged on support in recent years.
  • Congenital heart disease, renal failure, sepsis, stroke, and ECMO are significant predictors of hospital mortality.
  • Sepsis and VAD replacement/repair correlate with increased costs and longer hospital stays.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
271
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
199
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
260
Characteristics of Life01:23

Characteristics of Life

Biology is a natural science that studies life and living organisms, including their structure, function, development, interactions, evolution, distribution, and taxonomy. The field's scope is extensive and divided into several specialized disciplines, such as anatomy, physiology, ethology, genetics, and many more. All living things share a few key traits, including cellular organization, heritable genetic material and the ability to adapt/evolve, metabolism to regulate energy needs, the...
257.3K
Self-Help Support Groups01:28

Self-Help Support Groups

Self-help support groups are voluntary, community-based organizations that provide a platform for individuals with shared concerns to exchange support, insights, and practical strategies for coping with life challenges. Typically led by group members or paraprofessionals, these groups form a cornerstone of mental health care, especially in reaching populations that are underserved by traditional healthcare systems.
Accessibility and Cost-Effectiveness
One of the primary strengths of self-help...
339